Enter assignee name

Forward Citations = 9

Loading Chart...

12 inventors (with patents filed for the assignee):

Zhenkun Ma (8 out of 40 patents)

Jing Li (7 out of 11 patents)

Susan Harran (5 out of 16 patents)

4. Charles Z Ding (5 out of 23 patents)

5. In Ho Kim (5 out of 7 patents)

6. Keith D Combrink (4 out of 8 patents)

7. Yafei Jin (4 out of 8 patents)

8. Keith P Minor (4 out of 6 patents)

9. Jamie C Longgood (4 out of 4 patents)

10. Yong He (2 out of 2 patents)

11. Daniel Denton (1 out of 1 patent)

12. Timothy W Morris (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 7265107 - Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes (2007-09-04),

2. 7256187 - Rifamycin C-11 oxime derivatives effective against drug-resistant microbes (2007-08-14),

3. 7250413 - C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes (2007-07-31),

4. 7247634 - Rifamycin derivatives effective against drug-resistant microbes (2007-07-24),

5. 7238694 - Rifamycin imino derivatives effective against drug-resistant microbes (2007-07-03),

6. 7229996 - Rifamycin derivatives (2007-06-12),

7. 7226931 - (R/S) rifamycin derivatives, their preparations and pharmaceutical compositions (2007-06-05),

8. 7202246 - Spiro-rifamycin derivatives targeting RNA polymerase (2007-04-10),

Cumbre Pharmaceuticals Inc. is a leading biopharmaceutical company focused on developing innovative and life-changing medications. We specialize in oncology, rare diseases, and autoimmune disorders. Our mission is to improve the quality of life for patients through the development of novel therapies. With a team of dedicated scientists and researchers, we are committed to advancing medical science and bringing new treatment options to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

8 Patents

#244 in Dallas, TX

#2,223 in Texas

#34,919 in US

Dallas, TX, United States of America

Cumbre Pharmaceuticals Inc.